Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Results: Human albumin (0.1–10 mg/ml) dose-dependently increased NAG release and olmesartan or valsartan (10–9–10–7 mol/l) showed a significant reduction on albumin (1 mg/ml)-induced NAG release in RPTEC.”